GlaxoSmithKline says a federal judge in Chicago never should have allowed a jury to consider a widow’s claim that the London-based drugmaker was to blame for the death of her husband, an attorney who committed suicide after taking a generic version of the antidepressant Paxil.
In a brief filed Monday, GSK asked the 7th U.S. Circuit Court of Appeals to reverse the jury’s April 2017 $3 million award to Wendy Dolin, saying it cannot be liable for her husband’s death because he never took Paxil. Stewart Dolin, 57, a partner at Reed Smith LLP in Chicago, jumped in front of an oncoming commuter train in 2010 after taking paroxetine hydrochloride, a generic equivalent of Paxil manufactured by Mylan Labs.
To read the full story on Westlaw Practitioner Insights, click here: bit.ly/2rCWTVV